Publication:
Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: Are there specific patient characteristics or biomarkers to indicate response to treatment?

No Thumbnail Available
Date
2019-08-01T00:00:00Z
Authors
Kocaturk, E.
Baskan, E. B.
Engin, B.
Ozdemir, M.
KÜÇÜK, ÖZLEM SU
Can, P.
Ornek, S.
Hasal, E.
Atakan, N.
Journal Title
Journal ISSN
Volume Title
Publisher
Research Projects
Organizational Units
Journal Issue
Abstract
Description
Keywords
Kocaturk E., Baskan E. B. , Engin B., Ozdemir M., KÜÇÜK Ö. S. , Can P., Ornek S., Hasal E., Atakan N., -Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: Are there specific patient characteristics or biomarkers to indicate response to treatment?-, Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Lisbon, Portekiz, 1 - 05 Haziran 2019, cilt.74, ss.484-485
Citation
Sustainable Development Goals